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Summary 
Background: Providing written medicines information is being legislated in an increasing number of 
countries worldwide, with the patient information leaflet (PIL) being the most widely used method for 
conveying health information. The impact of providing such information on adherence to therapy is 
reportedly unpredictable. Therapy for human immunodeficiency virus/acquired immune deficiency 
syndrome (HIV/AIDS) and related opportunistic infections usually involves polytherapy and complex 
regimens, both of which are risk factors for non-adherence. The objective of this study was to assess the 
impact of medicines information on adherence to chronic co-trimoxazole therapy in low-literate 
HIV/AIDS patients. 
Methods: Two different PILs were designed for co-trimoxazole tablets and were available in both English 
and isiXhosa. Participants were randomly allocated to a control group (receiving no PIL), group A 
(receiving a 'complex PIL') and group B (receiving a 'simple PIL' incorporating pictograms). At the first 
interview, demographic data were collected and the time, date and day that the participant would take 
his/her first tablet of the month's course was also documented. In a follow-up interview adherence to 
therapy was assessed using two methods; self-report and tablet count. 
Results: The medicines information materials incorporating simple text and pictograms resulted in 
significantly improved adherence to therapy in the short term, whereas a non-significant increase in 
adherence was associated with the availability of the more complex information. This was shown by both 
the self-reported assessment as well as the tablet count. 
Conclusion: This research suggests that appropriately designed written material can have a positive impact 
in improving adherence and, together with verbal consultation, are essential for enabling patients to make 
appropriate decisions about their medicine taking. 
Introduction 
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2004 report of the global 
AIDS epidemic, an estimated 40 million people worldwide are infected with HIV. More than 95% live in 
low- and middle-income countries and approximately 70% of these people (28·1 million) live in Sub-
Saharan Africa (1). With the high levels of HIV infection, as well as the escalation of deaths from AIDS, 
South Africa is very much in the spotlight. The epidemic has become a serious development issue, with 
extremely far-reaching social, political and economic implications. Currently, it is estimated that 4·8 
million South Africans are infected with HIV/AIDS and 18 000 people die of AIDS every month, while 
600 people die every day (1). 
HIV is a virus that weakens the body's immune/defence system to such an extent that even mild 
opportunistic infections can result in death. Drug therapy for HIV/AIDS and related opportunistic 
infections is often complex, invariably involving polytherapy and is long term, all factors that have been 
shown to impact negatively on adherence. Non-adherence in HIV/AIDS patients has extremely serious 
consequences, making it vital to ensure good comprehension of medicines information in an effort to 
optimize adherence. Pneumocystis carinii pneumonia (PCP) is the most common, life-threatening 
opportunistic infection. It is caused by a parasite, which almost always presents itself as a lung infection, 
but can often spread to other organs (2). For the purpose of this research study, usage of co-trimoxazole 
tablets was reviewed as they are used both for the prevention and treatment of PCP. A constant 
concentration in the blood should be maintained, necessitating a high degree of adherence (2). 
The limited literacy skills of a large proportion of the South African population present a significant 
barrier to accessing and understanding medicines information necessary for the degree of adherence 
required for a successful therapeutic outcome. The challenge we as healthcare providers (HCPs) face is to 
communicate this information in an appropriate, understandable form commensurate with the patient's 
literacy skills, and, in addition, to ensure that it is acceptable in terms of the patient's culture, beliefs, 
attitudes and expectations. Written patient education material is made available to patients in the form of 
patient information leaflets (PILs), brochures and booklets. Unfortunately, in developing countries such as 
South Africa, much of this literature probably goes unused as a significant proportion of the population 
may not be able to read it and therefore will likely fail to obtain necessary preventative and therapeutic 
health services (3–5). Such individuals often do not understand what the HCP has said and are reluctant to 
ask for clarification or indicate that they do not understand. Complications in therapy may arise, as the 
inability to read and understand written information can interfere with adherence to a recommended 
regimen (4, 6). 
Poor patient adherence to prescribed therapy has evolved worldwide into a major public health problem, 
as it constitutes a significant barrier to the effective treatment of many acute and chronic diseases (7, 8). 
This is in part due to an increasing incidence of people taking drug therapy, the manufacture of more 
potent drugs, and the development of resistance to many anti-infective agents (9, 10). After decades of 
adherence research, very little consistent information is available, apart from the fact that people do not 
take their medicines as prescribed. 
One of the most interesting aspects of the adherence phenomenon is how rarely patients do all that is 
recommended by the HCP (11–13). One reviewer of the adherence literature has estimated that on average 
only one-third of patients correctly follow directions from their HCP (14). The reported incidence of non-
adherence to therapy ranges from 4% to 92% with an average non-adherence rate for chronic drug therapy 
of 50% (9, 15). The highest non-adherence rates have consistently been found in patients with chronic 
disorders involving long-term treatment and in whom the illness has asymptomatic periods during which 
the clinical consequences of non-adherence are often delayed (15), such as HIV/AIDS. 
Patients may have various reasons for not adhering to their therapy and can be regarded as either 
intentional or unintentional non-adherers. Unintentional failure to adhere to therapy can result from a 
number of factors, all of which are more likely to occur with increasing complexity of the regimen (9, 10, 
14–18). Forgetfulness, lack of information and/or knowledge, e.g. inadequate understanding of the disease 
or condition and lack of insight into the importance of continuing with the treatment, could result in 
unintentional failure to adhere to therapy (9, 10, 17, 19–21). 
According to Morris and Halperin (20) written medicines information, if designed appropriately, can 
improve adherence in short-term therapy, satisfy patient information needs and educate patients on the 
correct use of their medicine. It can also play an important role in making the patient more health 
conscious, aware of why and how to take medicines, and a more active participant in medical decisions. 
Written medicines information, such as PILs, with the appropriate tone, length and design can do much to 
aid responsible medicine taking (22, 23). 
The objective of this study was to assess the impact of written medicines information on adherence to co-
trimoxazole therapy in low-literate HIV/AIDS patients. 
 
Methods 
Study site and study population 
The study was conducted in Grahamstown, a small town in the largely rural Eastern Cape province. It is 
one of the poorest of the nine South African provinces with an extremely high unemployment rate (24). 
The majority of the local African population (84%) belongs to the Xhosa ethnic group and have isiXhosa 
as their home language. Eighteen per cent of the province's population aged 20 years and over have had no 
schooling at all, with only 8·4% holding a tertiary education (24). 
The majority of the interviews took place in five local primary health care clinics. Written permission 
from the relevant health authorities was obtained to conduct the research and patients signed consent 
forms when agreeing to participate in the study. Ethical approval for the study was obtained from the 
Rhodes University Ethical Standards Committee. 
The study population included participants over the age of 16 from a variety of educational backgrounds, 
ranging from no schooling at all up to a maximum of 12 years of formal education. An inclusion criterion 
was the ability to read and understand either English or isiXhosa. Approximately 120 HIV-positive 
outpatients on chronic co-trimoxazole therapy were identified and the initial interview was conducted on 
site. The follow-up interview, which took place approximately 14 days later, was conducted either at the 
participant's home or at the clinic. Participants were randomly allocated on an alternating basis to a control 
group (who received no PIL), group A (who received a longer, more 'complex PIL' containing no 
pictograms) and group B (who received a 'simple PIL' incorporating pictograms). 
 
Research material 
Two PILs were designed for co-trimoxazole tablets. Information sources consulted included Australian 
consumer medicines information (CMI), USP-DI, various fact sheets, medicine information sheets, 
monographs and package inserts (25–30). PILs were available in English and isiXhosa, and were printed 
back to back on white paper. 
The 'simple PIL' was a single A4 page in a Z-fold design, written in simple language and incorporating 
pictograms. Souvenir (bold) size 24 font was used for the main heading, which was in capital letters, and 
Souvenir (bold) size 14 font was used for the subheadings. In order to highlight the subheadings, a line 
was ruled above and below them. The text in the PIL was typed using Souvenir size 14 font and contained 
376 words. Special attention was paid to ensure the inclusion of uncomplicated words, translating medical 
terminology to commonly used plain language (where possible), as well as using short sentences to suit 
people with limited reading skills. The active voice was used and most of the information aimed at 
directly informing the patient about their therapy. In a previous study (31), a similar PIL that provided 
information about nystatin oral suspension was developed using the same format, layout, standard of text 
and visuals. This PIL was evaluated for readability and was shown to be well understood in a similar 
target population. 
The 'complex PIL' was printed on A4 paper and consisted of three columns, with a 1-cm gap between the 
columns. Helvetica (bold) size 26 font was used for the main heading, which was in capital letters, and 
Helvetica (bold) size 12 font was used for the subheadings. Again, in order to highlight the subheadings a 
line was ruled above and below them. The text in the PIL was typed using Arial size 10 font and contained 
643 words. The Australian CMI design and structure was used as a guide to devise this PIL (32). No 
pictograms were included and the PIL complied with all the specifications as stated in the South African 
legislation (33), resulting in a longer, more complicated PIL than the 'simple PIL'. 
 
Interview process and data collection 
Nursing sisters at the five clinics were notified about the study and were asked to recruit all HIV-positive 
patients currently taking co-trimoxazole tablets chronically. This was done using a standard approach, in 
which the nursing sister was instructed to explain the details of the study to the patient and ask if the 
patient would like to participate. On agreeing, permission to disclose the HIV-positive status to the 
interviewers was obtained. The patient was assured that all information would remain strictly confidential 
and was asked to read and sign a consent form. The nursing sister then notified us of a potential 
participant to interview. The co-trimoxazole tablets were dispensed according to normal clinic protocol, 
with a conventional medicine label. 
A standard approach was used for all interviews, which were conducted with the help of an interpreter. 
The date of the initial interview and the interview site was noted. The participant's name, address and 
contact number (if available) was recorded, as well as the current stage of HIV, which was obtained from 
the health passports. 
In the first interview demographic data such as gender, age, home language, current employment and 
educational level was collected. The time, date and day that the participant would take his/her first tablet 
of the month's course was documented. At the end of the first interview, all participants were asked to 
keep their tablet packets in a safe place and not to throw them away once finished. If the participant was 
allocated to either group A or B he/she was given the appropriate PIL and was instructed to read it 
carefully and to keep it in a safe place. To conclude this initial interview, participants were thanked for 
their time and given a reminder note stating the date, time and place of the follow-up interview, which 
took place approximately 14 days later, either at the participant's home or at the clinic. 
During the follow-up interview participant adherence with the co-trimoxazole tablets was assessed using 
two measures; self-report adherence and tablet count. The self-report assessment comprised a set of six 
questions that required the participants to explain how they were using their medicine. For example, 'How 
many tablets are you taking each time?' and 'How many times a day are you taking your tablets?' For the 
tablet count, permission was obtained from the participants to count the number of tablets that were still 
remaining in their tablet packet. Participants were offered a small honorarium at the conclusion of the 
interview and were thanked for their time. 
 
Data analysis 
For the self-report assessment of adherence, responses to questions asked about their therapy were marked 
as being either correct or incorrect and an adherence score was allocated. For the tablet count, the number 
of extra doses remaining in the medicine packet was calculated and a tablet count, the number of extra 
doses remaining in the medicine packet was calculated and a second adherence score was allocated. The 
overall percentage for participant adherence was calculated using the following formula: 
 
This equation was formulated based on the heavily weighted objective assessment of the tablet count but 
also taking cognizance of the more subjective self-report measure.#10; 
 
Results 
Demographic characteristics 
A total of 138 participants were approached to participate in the study; 11 participants refused for various 
reasons and a further seven were lost to follow-up. A final total of 120 participants were recruited and 
interviewed, and their demographic characteristics are presented in Table 1. Participants were all Black, 
isiXhosa-speaking and HIV-positive patients, with co-trimoxazole tablets being part of their current drug 
regimen. 
The majority (69·2%) of the participants were in stage 4 (asymptomatic stage) of their disease, with 31% 
being in stage 5 (AIDS-related complex). During stage 4 no signs or symptoms are visible and the patient 
is prescribed co-trimoxazole tablets prophylactically to prevent opportunistic infections such as PCP. 
Most (60·8%) of the participants were between the ages of 26 and 40 years and more than two-thirds 
(73·3%) were female. Just under half (44·2%) had between 8 and 12 years of formal education, 44 
(36·7%) participants had been to school for between 5 and 7 years, and seven (5·8%) participants had no 
formal education. All participants interviewed were from a socioeconomically disadvantaged background 
and this was clearly demonstrated by the fact that only 11 (9·2%) participants were employed at the time 
of the study. Only five (4·2%) participants were unable to tell the time from a clock face, but all could 
interpret a digital face. 
 
Assessment of participant adherence 
For the self-report assessment, when the participants were asked 'Have you been taking your tablets as 
directed?' only one participant acknowledged that she was not doing so. However, Table 2 clearly 
illustrates the unreliability of this as a sole measure of adherence as only 28 (70·0%) participants in the 
control group knew how many tablets to take and when to take them. This improved to 78% in group A 
(complex PIL) and 92·5% in group B (simple PIL). This suggests that the PIL, together with the 
information on the medicine label was useful in promoting understanding of how to take the medicine 
correctly. The other questions were all answered relatively well, indicating that overall 80% of the 
participants were apparently 100% adherent with their medicine. 
When comparing adherence (self-report) between groups (Table 2), significantly more participants in 
group B (92·5%) obtained 100% adherence when compared with those participants in the control group 
(70·0%). This indicates that the presence of pictograms may have a positive influence on adherence to 
short-term therapy. One hundred per cent adherence was also achieved by 31 (78%) participants in group 
A (complex PIL). 
The results from the tablet count concurred with the self-report assessment and showed that the mean 
percentage adherence was significantly higher in those participants who received the 'simple PIL' (86·5%) 
when compared with the control group (65·1%) or group A (70·1%). A significant difference was 
observed between the number of participants who achieved 100% adherence in the group who received 
the 'simple PIL' (35%) compared with the other two groups (2·5% in each group). 
When combining results from the self-report and tablet count using the above-mentioned formula, it was 
found that the overall mean percentage adherence of the participants in group B (88·3%) was significantly 
higher than those in group A (73·6%), as well as in the control group (67·7%). 
 
Discussion 
In the past few decades, hundreds of research articles have been published on non-adherence, and dozens 
of devices and programmes have been developed to assess and attempt to resolve adherence-related 
problems. Yet, despite the tremendous efforts of pharmacists and other HCPs, non-adherence to 
prescribed therapy remains a significant health problem resulting in poor patient outcomes and increased 
healthcare use (8, 12, 13). In people with limited literacy, lack of cognitive skills is undoubtedly a 
contributing factor to non-adherence. This research has illustrated the positive influence of improved 
understanding of medicines information on patient adherence to short-term therapy and highlighted the 
need for simple, understandable text and visual aids such as pictograms in medicines information material. 
The problem of non-adherence affects all populations, however some are more vulnerable than others. 
High-risk populations such as those with low literacy skills, or people with disease states such as 
HIV/AIDS, who require complex drug regimens, should be identified and targeted for intervention studies 
(8). Poirier and NicholsEnglish (34) have recommended that HCPs should strive to provide medicines 
information materials that are written at a low-literacy level in order to help improve patient adherence to 
therapy in these high-risk populations. They suggest that medicines information materials should be short, 
simple and contain culturally sensitive pictograms, and be used in combination with verbal instructions. 
This was the approach adopted in this study where PILs were designed in collaboration with the target 
population and were provided to the low-literate Xhosa participants in their home language. The results of 
this intervention showed that significantly higher adherence to short-term therapy was noted for those 
participants who received the PIL incorporating simple text and pictograms. These findings support those 
of Dowse and Ehlers (35), as well as Ngoh and Shepherd (36) who reported significantly higher 
comprehension and adherence measures in the patient group that received visual aids. 
Kitching (37) stated that 'Lack of information has been identified as a major factor among 250 reasons 
why patients do not take their medicines as the prescriber intends', a statement supported by the results of 
this study in which the highest percentage adherence was associated with receipt of a PIL containing 
simple text and pictograms. Adherence in these cases was found to be significantly higher than in cases 
where no written information at all was provided. These results clearly show the positive influence of 
receiving medicines information on the ability to achieve a high level of adherence to therapy and were in 
accordance with the findings of Regner et al. (38), who suggested that written materials such as PILs are 
essential for enabling patients to make appropriate decisions about their medicine taking. 
Research has shown that drug information should be written in the simplest manner possible so that it is 
understood and judged as understandable by patients (39, 40). Previous research conducted by Mansoor 
and Dowse (31) showed that the presence of pictograms and simple text on medicines information 
materials significantly improved the understanding of instructions. Participants in this study also 
expressed an overwhelmingly positive desire for pictograms in their drug information. Materials written at 
a higher level may serve to depress understanding and clarity (40), preventing the patients from becoming 
active, responsible partners and informed decision makers in their health care (41). In fact, complex 
medicines information may adversely affect understanding, lead to unnecessary confusion which, in turn, 
may negatively affect adherence to therapy. Although this overtly negative effect was not apparent in this 
study, it was observed that only a non-significant increase in adherence was associated with the 
availability of the more complex information, whereas a significant increase in adherence was measured in 
the participants who received the simply written information illustrated with pictograms. 
The relationship between improved understanding and adherence is generally a contentious issue; 
however, in this low-literate population with poor reading skills, a direct relationship was observed 
between understanding of the information received and adherence to therapy. Understanding of the PILs 
was assessed using the same methodology as described by Mansoor and Dowse (31), with the mean 
percentage understanding of the 'simple PIL' being significantly higher (90·8%) than that of the 'complex 
PIL' (62·7%). The participants regarded the 'complex PIL' as too long and complicated, with unnecessary 
information, therefore the PIL incorporating simple text and pictograms was considered to be more 
desirable. Availability of this more complicated PIL had no significant effect on either understanding or 
adherence to therapy. 
Measuring adherence is well known to be problematic, however before effective strategies can be devised 
to improve adherence, HCPs need to assess adherence and identify risk factors that may predispose the 
individual to non-adherence. Both direct and indirect methods are available to assess adherence. The 
available information suggests that self-report and tablet count would constitute the most adequate 
methods for measuring adherence in developing countries (16). The self-report assessment method is 
inexpensive and allows the HCP to interact empathetically with the patient and provide immediate 
feedback. However, accuracy of reporting depends on the cognitive abilities and honesty of the patient, as 
well as the correct interpretation of these reports by the HCP (42, 43). 
Self-report has been criticized on the grounds that participants are unlikely to 'tell the truth', although 
some researchers (44, 45) have shown the self-report method to be acceptable. These researchers also 
agreed that patients generally tended to over-estimate their adherence with the important exception of 
those who acknowledged their non-adherence, where the reports were accurate. Our results showed 
similar findings especially when participants were asked for a direct global self-opinion of their 
adherence; however, the more in-depth, penetrating questions were answered more honestly. 
Haynes et al. (44) commented that tablet count might be an awkward method of assessing adherence, 
although it may be accurate if the patient is unaware of the purpose of the assessment. Tablet counts 
provide an objective measure of the quantity of drug taken over a given time period, but this method is 
time consuming and assumes that medicine not in the container was consumed (42, 43, 45). Despite these 
shortcomings, our results from the self-report assessment agreed with the tablet count, therefore indicating 
reasonable consistency in these two different methods of assessing adherence. 
In conclusion, successful therapy depends not only on taking the appropriate drug, but also on taking it in 
the appropriate way. This can only be achieved if the patient can access and understand the information 
and then act upon it. A more informed patient enables greater participation in the decision-making 
process, resulting in a positive impact on medicine-taking behaviour and health outcomes. Knowledge of 
interventions shown to improve adherence provides the HCP with tools with which to improve medicine 
adherence. Persistent and consistent monitoring and reassessment leads to positive rewards of improved 
medicine adherence and patient health. 
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